Experts say early intervention is key to treating and coping with dementia or Alzheimer's. Here's what to keep an eye out for ...

Jeffrey Stark, MD, vice president and head of medical immunology at UCB, discusses tailored dosing of bimekizumab-bkzx (Bimzelx) for various inflammatory conditions, highlighting its 5 FDA approvals ...

Six new drugs, including a treatment for patients with advanced breast cancer, have been approved for use by the NHS in ...

Explore the potential of monoclonal antibodies in Alzheimer’s treatment, including breakthroughs and challenges in this ...

The first drug proven to slow down Alzheimer's won't be available to dementia patients in Scotland - unless they pay £60,000 ...

There isn't a cure for the condition, but doctors may recommend medications to slow down the progression of the disease or ...

The first drug proven to slow down Alzheimer's won't be available to dementia patients in Scotland - unless they pay £60,000 ...

Diabetes is a common, lifelong condition that occurs when the pancreas doesn't produce enough insulin, or when the body is unable to effectively use the insulin it produces ...

A new biomarker test developed at the University of Pittsburgh could help doctors doctors detect signs of Alzheimer's years sooner, according to research published Monday in Nature Medicine.

Two new medications, called lecanemab and donanemab, have shown success in clinical trials in slowing down Alzheimer’s disease. These are known as disease-modifying treatments and have been licensed ...

The hypothesis puts forward the idea that stress granules disrupt the cell transport system, which then modifies gene ...